HomeEntertainmentEnovis CAO Oliver Engert acquires $25,948 in company stock Enovis CAO Oliver Engert acquires $25,948 in company stock June 16, 2026byadmin Enovis CAO Oliver Engert acquires $25,948 in company stock Source link
Replimune reaches agreement with FDA on melanoma drug resubmission Replimune reaches agreement with FDA on melanoma drug resubmission Source link
Amaze Holdings CEO Aaron Day buys $63,543 in company stock Amaze Holdings CEO Aaron Day buys $63,543 in company stock Source link